Cardiac Ablation Market
Cardiac Ablation Market Research and Forecast 2017-2022 Update Available - Forecast 2024-2030
The global cardiac ablation market was estimated to USD 2,080 million in 2018 and expected to grow at a CAGR of 12.6% during the forecast period. Cardiac ablation is the process that is used for the treatment of heart rhythm problems. Cardiac ablation destroys the tissues in heart that triggers abnormal heart rhythm. Cardiac ablation generally uses catheters, which are inserted through arteries or vein in the body to deliver energy in heart to modify the tissue that causes arrhythmia. Cardiac ablation can also be performed via open heart surgery, however it is often done using catheters, which makes the procedure less invasive and reduces the recovery time. Although the procedure mainly depends upon the physical condition and malaise faced by patient. Cardiac ablation is widely used in the treatment of arrhythmias, atrial fibrillation, Wolff-Parkinson-White (WPW) syndrome, tachycardia, atrial flutter etc. these are the major application of cardiac ablation that is augmenting the demand of the procedure. The global cardiac ablation market is anticipated to grow with the CAGR of 12.6% during 2017-2022. Increasing geriatric population, rising prevalence of cardiovascular diseases are estimated to be the major factors that are augmenting the growth of the cardiac ablation market. Moreover, technological advancement in cardiac ablation and rise in the adoption of minimally invasive procedures with better medical imaging are also estimated to drive the growth of the cardiac ablation market. However, high cost containment measures taken by governments and changing healthcare reform in United States are estimated to be the major constraints in the growth of the market.
Global cardiac ablation market is studied in detail by segmenting the market on the basis of the crucial criteria such as on the basis of technology, and on the basis of applications. On the basis of technology, cardiac ablation market is further segmented into electrical ablation, microwave ablation, radiofrequency ablation, and ultrasound ablation. Further on the basis of applications, our market is bifurcated into cardiac rhythm management, open surgery and others.
Geography insights
Global cardiac ablation market is further studied on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America, Europe, Asia Pacific and Rest of the World are major geographical regions in the cardiac ablation market. North America is estimated to account for major share in the global cardiac ablation market owing to high prevalence of cardio vascular diseases in the region. Further well established healthcare infrastructure are also estimated to back the growth of the market in the region. Asia Pacific is estimated to be the fastest growing region during the forecast period owing to increasing healthcare expenditure in the region and rising geriatric population across the region.
Competitive insights
Key players of the cardiac ablation market are AblaCor, Advanced Cardiac Therapeutics, Alcon Laboratories Inc., AngioDynamics, Atricure Inc., Baren-Boym, Bioscience Webster, Boston Scientific Corporation, Conmed Corporation, Covidien, Ethicon, Huainan Aofu Surgical Instruments, Medsphere, Medtronic Plc, Mount Sinai Corp., Olympus Corporation, St. Jude Medical Inc., ZenoMed and so on.
The report covers
• Comprehensive research methodology of global cardiac ablation market
• This report also includes detailed and extensive market overview with Analyst insights & key market trends.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global cardiac ablation market
• Insights about market determinants which are stimulating the global cardiac ablation market
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. GLOBAL CARDIOLOGY MARKET AT A GLANCE
2.2. ANALYST & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1. TAX LAWS
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
2.3.2. DRUGS AND DEVICE REGULATIONS
2.3.2.1. UNITED STATES
2.3.2.2. EUROPEAN UNION
2.3.2.3. CHINA
2.3.2.4. INDIA
2.3.2.5. REST OF THE WORLD
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING GERIATRIC POPULATION
3.1.2. INCREASING INCIDENCE AND PREVALENCE OF CARDIOVASCULAR DISEASES
3.1.3. TECHNOLOGICAL ADVANCEMENTS
3.1.4. RISE IN ADOPTION OF MINIMALLY INVASIVE PROCEDURES WITH BETTER MEDICAL IMAGING
3.1.5. RISING HEALTHCARE EXPENDITURE
3.2. RESTRAINTS
3.2.1. HIGH COST CONTAINMENT MEASURE TAKEN BY GOVERNMENTS
3.2.2. HEALTHCARE REFORMS IN US
3.3. OPPORTUNITIES
3.3.1. EMERGENCE OF MICROWAVE ABLATION PROCEDURE IN CLINICAL TRIALS
3.3.2. GROWING ADOPTION OF ABLATION IN CARDIOVASCULAR DISEASES TREATMENT
CHAPTER 4. MARKET SEGMENTATION
4.1. CARDIAC ABLATION BY TECHNOLOGY
4.1.1. CRYOABLATION
4.1.2. ELECTRICAL AND RADIOFREQUENCY ABLATION
4.1.3. MICROWAVE ABLATION
4.1.4. ULTRASOUND ABLATION
4.2. GLOBAL CARDIAC ABLATION MARKET BY APPLICATION
4.2.1. MINIMALLY INVASIVE SURGERY
4.2.2. OPEN SURGERY
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICA
6.2. EUROPE
6.2.1. UK
6.2.2. FRANCE
6.2.3. GERMANY
6.2.4. ITALY
6.2.5. SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. KOREA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.5. TAIWAN
6.4. REST OF THE WORLD
CHAPTER 7. COMPANY PROFILES
7.1. ABLACOR
7.1.1. INTRODUCTION
7.1.2. ABLACOR PRODUCT PORTFOLIO
7.1.3. ABLACOR RECENT ACTIVITIES
7.2. ADVANCED CARDIAC THERAPEUTICS
7.2.1. INTRODUCTION
7.2.2. ADVANCED CARDIAC THERAPEUTICS PRODUCT PORTFOLIO
7.2.3. ADVANCED CARDIAC THERAPEUTICS RECENT ACTIVITIES
7.3. ANGIODYNAMICS
7.3.1. INTRODUCTION
7.3.2. ANGIODYNAMICS PRODUCT PORTFOLIO
7.4. ATRICURE INC.
7.4.1. INTRODUCTION
7.4.2. ATRICURE INC. PRODUCT PORTFOLIO
7.4.3. ATRICURE INC. RECENT ACTIVITIES
7.5. BAREN-BOYM
7.5.1. INTRODUCTION
7.5.2. BAREN-BOYM PRODUCT PORTFOLIO
7.6. BIOSENSE WEBSTER
7.6.1. BIOSENSE WEBSTER, INC. INTRODUCTION
7.6.2. BIOSENSE WEBSTER, INC. PRODUCT PORTFOLIO
7.6.3. BIOSENSE WEBSTER, INC. RECENT DEVELOPMENTS
7.7. BOSTON SCIENTIFIC CORPORATION
7.7.1. INTRODUCTION
7.7.2. BOSTON SCIENTIFIC CORPORATION PRODUCT PORTFOLIO
7.7.3. BOSTON SCIENTIFIC CORPORATION RECENT ACTIVITIES
7.8. CONMED CORPORATION
7.8.1. INTRODUCTION
7.8.2. CONMED CORPORATION PRODUCT PORTFOLIO
7.8.3. CONMED CORPORATION RECENT ACTIVITIES
7.9. ETHICON
7.9.1. INTRODUCTION
7.9.2. ETHICON PRODUCT PORTFOLIO
7.9.3. ETHICON RECENT DEVELOPMENTS
7.10. HANSEN MEDICAL
7.10.1. INTRODUCTION
7.10.2. HANSEN MEDICAL PRODUCT PORTFOLIO
7.11. HOLLISTER INC.
7.11.1. INTRODUCTION
7.11.2. HOLLISTER INC.PRODUCT PORTFOLIO
7.11.3. HOLLISTER INC.RECENT ACTIVITIES
7.12. MEDTRONICS PLC. (COVIDIEN LTD.)
7.12.1. INTRODUCTION
7.12.2. MEDTRONICS PLC PRODUCT PORTFOLIO
7.13. MOUNT SINAI CORPORATION
7.13.1. INTRODUCTION
7.13.2. MOUNT SINAI CORPORATION PRODUCT PORTFOLIO
7.14. OLYMPUS CORPORATION
7.14.1. INTRODUCTION
7.14.2. OLYMPUS CORPORATION PRODUCT PORTFOLIO
7.14.3. OLYMPUS CORPORATION RECENT DEVELOPMENTS
7.15. ST. JUDE MEDICAL INC.
7.15.1. INTRODUCTION
7.15.2. ST. JUDE MEDICAL INC. PRODUCT PORTFOLIO
7.15.3. ST. JUDE MEDICAL INC. RECENT DEVELOPMENTS
7.16. ZENOMED
7.16.1. INTRODUCTION
7.16.2. ZENOMED PRODUCT PORTFOLIO
TABLE # 1 GLOBAL CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHICAL REGIONS, 2015-2022 ($ MILLIONS)
TABLE # 2 GLOBAL CARDIOLOGY DRUGS, DEVICES AND SURGERIES MARKET RESEARCH AND ANALYSIS 2015-2021 ($MILLION)
TABLE # 3 GLOBAL CARDIOLOGY MARKET, REGIONAL DISTRIBUTION, 2015-2021 ($MILLION)
TABLE # 4 GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH AND ANALYSIS, 2015-2021 ($MILLION)
TABLE # 5 KEY FACTS RELATED TO CVDS AT GLOBAL AND COUNTRY LEVEL
TABLE # 6 BOSTON SCIENTIFIC IMAGING CATHETER FEATURES (OPTIPLUS SERIES)
TABLE # 7 HEART ARRHYTHMIA - CATHETER ABLATION GLOBAL PRICE COMPARISION (2017)
TABLE # 8 ACCEPTABLE ENDPOINT CRITERIA
TABLE # 9 SAFETY AND EFFECTIVENESS OF RF ABLATION USING CONVENTIONAL RF ABLATION CATHETERS
TABLE # 10 GLOBAL CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2015-2022 ($MILLION)
TABLE # 11 GLOBAL CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 12 GLOBAL CYROABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 13 GLOBAL ELECTRICAL AND RADIO-FREQUENCY ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 14 GLOBAL MICROWAVE ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 15 GLOBAL ULTRASOUND ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 16 GLOBAL CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2015-2022 ($MILLION)
TABLE # 17 GLOBAL CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 18 GLOBAL MINIMALLY INVASIVE SURGERY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($MILLION)
TABLE # 19 GLOBAL MINIMALLY INVASIVE SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 20 GLOBAL TACHYCARDIA MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 21 GLOBAL ATRIAL FIBRILLATION SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 22 GLOBAL OPEN SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($MILLION)
TABLE # 23 KEY STRATEGIES OF LEADING PLAYERS, JAN 2015-OCT 2017
TABLE # 24 RECENT DEVELOPMENT IN CARDIAC ABLATION MARKET
TABLE # 25 KEY ACTIVITIES OF LEADING PLAYERS, JAN 2015-OCT 2017
TABLE # 26 GLOBAL CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2015-2022 ($ MILLION)
TABLE # 27 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2022
TABLE # 28 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2015-2022
TABLE # 29 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2015-2022
TABLE # 30 CVD COSTS THROUGH 2035
TABLE # 31 HEALTH EXPENDITURES US, 2014
TABLE # 32 STATISTICS OF CVD AND OTHER HEART DISEASES IN CANADA, 2012
TABLE # 33 EUROPEAN CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE # 34 EUROPEAN MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2015-2022, ($ MILLION)
TABLE # 35 EUROPEAN MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2015-2022, ($ MILLION)
TABLE # 36 CVD STATISTICS EUROPE, 2014
TABLE # 37 STATISTICS RELATED TO CHD, CVD AND STROKE, UK
TABLE # 38 ASIA PACIFIC CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 39 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2015-2022 ($ MILLION)
TABLE # 40 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2015-2022 ($ MILLION)
TABLE # 41 STATISTICS RELATED TO CHD, COST OF SURGERIES AND MAJOR HOSPITALS IN INDIA, 2014
TABLE # 42 STATISTICS OF CVD, CHD, MEDICAL DEVICE IN CHINA 2014
TABLE # 43 REST OF THE WORLD CARDIAC ABLATION MARKET BY TECHNOLOGY, 2015-2022 ($MILLION)
TABLE # 44 REST OF THE WORLD CARDIAC ABLATION MARKET BY APPLICATION, 2015-2022 ($MILLION)
FIGURE # 1 GLOBAL CARDIAC ABLATION MARKET, BY TECHNOLOGY, 2016 AND 2022, (%)
FIGURE # 1 GLOBAL CARDIAC ABLATION MARKET, BY TECHNOLOGY, 2016 AND 2022, (%)
FIGURE # 2 THE GLOBAL CARDIOLOGY DEVICES MARKET BY CATHETERS, 2015-2021, ($ MILLION)
FIGURE # 3 THE GLOBAL CARDIOLOGY DEVICES MARKET BY CARDIAC RHYTHM MANAGEMENT, 2015-2021, ($ MILLION)
FIGURE # 4 POPULATION AGED 60 YEARS OR OVER (IN MILLION)
FIGURE # 5 FATALITIES DUE TO CVD 2012 & 2030 (MILLIONS)
FIGURE # 6 CVD COST TO THE GLOBAL ECONOMY 2010 & 2030 ($ BILLIONS)
FIGURE # 7 FATALITIES FROM CORONARY ARTERY DISEASES 2012 AND 2020 (MILLIONS)
FIGURE # 8 ESTIMATED TOTAL COSTS OF CVDS IN THE U.S., 2015-2030 ($ BILLIONS)
FIGURE # 9 GLOBAL HEALTHCARE EXPENDITURE, 2012-2014 (% OF GDP)
FIGURE # 10 HEALTHCARE EXPENDITURE OF DEVELOPED ECONOMIES, 2014 (% OF THEIR GDP)
FIGURE # 11 HEALTHCARE EXPENDITURE OF DEVELOPING ECONOMIES, 2014(% OF THEIR GDP)
FIGURE # 12 PREVALENCE OF CARDIOVASCULAR DISEASE IN THE US, 2015 (IN MILLIONS)
FIGURE # 13 US CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($MILLION)
FIGURE # 14 CANADA CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION
FIGURE # 15 PREVALENCE RATE OF CVDS BY AGE GROUP IN CANADA, 2014
FIGURE # 16 UK CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE # 17 FRANCE CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE # 18 GERMANY CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE # 19 ITALY CARDIOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE # 20 SPAIN CARDIAC ABLATIONMARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE # 21 ADULT POPULATION WITH AGE 60+ IN DIFFERENT COUNTRIES (2015 AND 2050)
FIGURE # 22 INDIAN CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($MILLION)
FIGURE # 23 CHINA CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE # 24 JAPAN CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022, ($MILLION)
